184 related articles for article (PubMed ID: 20728514)
21. Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate.
Albertini B; Passerini N; Di Sabatino M; Vitali B; Brigidi P; Rodriguez L
Eur J Pharm Sci; 2009 Mar; 36(4-5):591-601. PubMed ID: 19150403
[TBL] [Abstract][Full Text] [Related]
22. Spray-dried Amioca starch/Carbopol 974P mixtures as buccal bioadhesive carriers.
Ameye D; Mus D; Foreman P; Remon JP
Int J Pharm; 2005 Sep; 301(1-2):170-80. PubMed ID: 16019172
[TBL] [Abstract][Full Text] [Related]
23. Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery.
Cafaggi S; Leardi R; Parodi B; Caviglioli G; Russo E; Bignardi G
J Control Release; 2005 Jan; 102(1):159-69. PubMed ID: 15653142
[TBL] [Abstract][Full Text] [Related]
24. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
[TBL] [Abstract][Full Text] [Related]
25. Oral transmucosal delivery of naratriptan.
Sattar M; Lane ME
Int J Pharm; 2016 Nov; 514(1):263-269. PubMed ID: 27863671
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: part I.
De Caro V; Giandalia G; Siragusa MG; Paderni C; Campisi G; Giannola LI
Eur J Pharm Biopharm; 2008 Nov; 70(3):869-73. PubMed ID: 18647652
[TBL] [Abstract][Full Text] [Related]
27. Development of an ex vivo retention model simulating bioadhesion in the oral cavity using human saliva and physiologically relevant irrigation media.
Madsen KD; Sander C; Baldursdottir S; Pedersen AM; Jacobsen J
Int J Pharm; 2013 May; 448(2):373-81. PubMed ID: 23538096
[TBL] [Abstract][Full Text] [Related]
28. Buccoadhesive films for once-a-day administration of rivastigmine: systematic formulation development and pharmacokinetic evaluation.
Kapil R; Dhawan S; Beg S; Singh B
Drug Dev Ind Pharm; 2013 Mar; 39(3):466-80. PubMed ID: 22409834
[TBL] [Abstract][Full Text] [Related]
29. Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: In-vitro/in-vivo evaluation.
Fouad SA; Shamma RN; Basalious EB; El-Nabarawi MA; Tayel SA
Int J Pharm; 2016 May; 505(1-2):212-22. PubMed ID: 27063851
[TBL] [Abstract][Full Text] [Related]
30. Controlled release of growth hormone from thermosensitive triblock copolymer systems: In vitro and in vivo evaluation.
Chen S; Singh J
Int J Pharm; 2008 Mar; 352(1-2):58-65. PubMed ID: 18036752
[TBL] [Abstract][Full Text] [Related]
31. Preparation of monolithic osmotic pump system by coating the indented core tablet.
Liu L; Che B
Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo evaluation of a novel mucoadhesive buccal oxytocin tablet prepared with Dillenia indica fruit mucilage.
Metia PK; Bandyopadhyay AK
Pharmazie; 2008 Apr; 63(4):270-4. PubMed ID: 18468385
[TBL] [Abstract][Full Text] [Related]
33. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.
Allam A; Fetih G
Drug Des Devel Ther; 2016; 10():2421-33. PubMed ID: 27536063
[TBL] [Abstract][Full Text] [Related]
34. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
[TBL] [Abstract][Full Text] [Related]
35. Critical evaluation of permeation enhancers for oral mucosal drug delivery.
Sohi H; Ahuja A; Ahmad FJ; Khar RK
Drug Dev Ind Pharm; 2010 Mar; 36(3):254-82. PubMed ID: 19663558
[TBL] [Abstract][Full Text] [Related]
36. Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy.
Lo JB; Appel LE; Herbig SM; McCray SB; Thombre AG
Drug Dev Ind Pharm; 2009 Dec; 35(12):1522-9. PubMed ID: 19929212
[TBL] [Abstract][Full Text] [Related]
37. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
[TBL] [Abstract][Full Text] [Related]
38. HO-1-u-1 model for screening sublingual drug delivery--influence of pH, osmolarity and permeation enhancer.
Wang Y; Zuo Z; Chow MS
Int J Pharm; 2009 Mar; 370(1-2):68-74. PubMed ID: 19071203
[TBL] [Abstract][Full Text] [Related]
39. A biorelevant in vitro release/permeation system for oral transmucosal dosage forms.
Delvadia PR; Barr WH; Karnes HT
Int J Pharm; 2012 Jul; 430(1-2):104-13. PubMed ID: 22486954
[TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
